IQVIA Holdings IQV · USD
Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States
S&P 500
278.84
+2.58%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About IQVIA Holdings
From its filings with the US Securities and Exchange Commission
IQVIA Holdings is based in Durham, North Carolina and is incorporated in Delaware. Its shares trade on NYSE under the ticker IQV. It is a member of the S&P 500. The SEC classifies its business as commercial physical & biological research. In the fiscal year to 31 December 2025, it reported revenue of $16.31bn and net income of $1.36bn. At that date it held total assets of $29.94bn and shareholders' equity of $6.50bn. By business, Research & Development Solutions brought in 54.5% of revenue, followed by Technology & Analytics Solutions at 40.6% and Contract Sales & Medical Solutions at 4.8%. By region, Americas accounted for 47.5%, followed by Europe and Africa at 31.8% and Asia-Pacific at 20.7%.
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. We are committed to using artificial intelligence ("AI") responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 93,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, we are dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
We are a global leader in protecting individual patient privacy. We use a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes.
Quoted from its 10-K, filed 17 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 9 May 2013
- Employees
- 93,000
- Website
- ir.iqvia.com ↗
- Head office
- 2400 ELLIS ROAD, DURHAM, NC, 27703
- Incorporated in
- DE
- Classification
- Services-Commercial Physical & Biological Research
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Ari BousbibChairman of the Board, Chief Executive Officer, since 2016$26.7m
- Mr. Ronald BruehlmanChief Financial Officer, Executive Vice President$8.4m
- Mr. Bhavik PatelPresident, Commercial Solutions$3.0m
- Mr. Walter StaubPresident - Research and Development Solutions$10.7m
- Mr. Eric SherbetExecutive Vice President, General Counsel, Secretary$4.2m
- Dr. John LeonardLead Independent Director$411,160
- Ms. Carol BurtIndependent Director$382,410
- Mr. John ConnaughtonIndependent Director$349,910
- Mr. John DanhaklIndependent Director$359,910
- Mr. James FasanoIndependent Director$379,910
- Ms. Colleen GogginsIndependent Director$379,910
- Ms. Leslie MorrisIndependent Director$349,910
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 67
- Environment
- 50
- Social
- 99
- Governance
- 51
- Women in the workforce
- 62%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Diverse Portfolio: IQVIA Holdings Inc offers a wide range of healthcare and pharmaceutical services, including clinical trial management, data analytics, and consulting.
- Strong Global Presence: With operations in over 100 countries, IQVIA has established a strong international market presence, allowing it to serve clients worldwide.
- Technological Advancements: The company leverages innovative technologies, such as artificial intelligence and cloud computing, to drive efficiency and improve its service offerings.
Weaknesses
- Dependency on Key Clients: IQVIA relies heavily on a few large pharmaceutical companies for a significant portion of its revenue, making it vulnerable to changes in client relationships.
- Regulatory Challenges: The healthcare industry is subject to strict regulations and compliance requirements, which can pose challenges for IQVIA in terms of navigating complex regulatory frameworks.
- Limited Product Differentiation: Some of IQVIA's services may face competition from similar offerings in the market, making it important for the company to continuously innovate and differentiate itself.
Opportunities
- Growing Healthcare Industry: The increasing importance of healthcare services presents opportunities for IQVIA to expand its client base and offer its expertise in an evolving market.
- Emerging Markets: IQVIA can tap into the potential of emerging markets, particularly in Asia and Latin America, where healthcare spending and demand for pharmaceutical services are on the rise.
- Data Analytics Potential: The increasing availability and relevance of data in the healthcare industry provide IQVIA with opportunities to leverage its data analytics capabilities and offer valuable insights to clients.
Threats
- Economic Uncertainty: Changes in global economic conditions and financial instability can affect healthcare spending, potentially impacting IQVIA's revenue and growth prospects.
- Competitive Landscape: The healthcare and pharmaceutical services industry is highly competitive, with the presence of both established players and new entrants, which may pose challenges for IQVIA.
- Data Security Risks: As IQVIA deals with sensitive healthcare data, it faces the ongoing challenge of ensuring data privacy and protection against cyber threats and breaches.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.